Jeff George has two decades of global healthcare and corporate leadership experience across North America, Europe, and emerging markets. Jeff is the Managing Partner of Maytal Capital, a healthcare-focused venture and private equity firm he founded in January 2017, and an Operating Partner at Revival Healthcare Capital since December 2018, a medical device-focused private equity firm.
Between 2008 and 2016, Jeff served on the Executive Committee of Novartis Group (NYSE: NVS), first as CEO and Division Head of Germany-based Sandoz, Novartis’s $10 billion revenue generic pharmaceutical and biosimilar subsidiary. He was then CEO and Division Head of Texas-based Alcon, Novartis’s ~$10 billion revenue ophthalmology subsidiary.
Earlier in his career, Jeff served as head of Emerging Markets at Novartis Pharmaceuticals, as Vice President and Head of Western & Eastern Europe for Novartis Vaccines, as a Senior Director of Strategic Planning & Business Development at Gap Inc. (NYSE: GPS), and as Engagement Manager with McKinsey & Co.
Jeff is currently Chairman of the Board of Directors at MAPS Public Benefit Corporation, which has an FDA-designated breakthrough therapy for PTSD that has successfully completed two Phase 3 clinical trials. He also serves on the board of directors at Amneal Pharmaceuticals (NYSE: AMRX), a leading specialty and generic pharmaceuticals company, as well as Dorian Therapeutics, a pre-clinical biotechnology company focused on cellular anti-senescence which was spun out of Stanford in 2018. He also serves on the board of directors for several non-profit organizations including Education Opens Doors, where he is Chairman, the North Texas Food Bank, and YPO of Dallas. Jeff previously served on the board of directors of Roam Analytics, an artificial intelligence healthcare software firm; Wishbone Medical, a pediatric orthopedic medical device company; and AdvaMed, the medical device industry association.
Jeff holds an MBA from Harvard Business School, a master’s degree from Johns Hopkins University’s School of Advanced International Studies, and a bachelor’s degree in international relations from Carleton College.